| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,043 |
4,840 |
$70K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
3,808 |
3,439 |
$44K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,003 |
986 |
$33K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,584 |
1,518 |
$9K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
668 |
666 |
$5K |
| 99307 |
|
640 |
509 |
$3K |
| 0012A |
|
33 |
33 |
$1K |
| 0011A |
|
36 |
35 |
$986.42 |
| 93000 |
|
83 |
83 |
$961.61 |
| 36415 |
Collection of venous blood by venipuncture |
5,844 |
5,764 |
$873.85 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
43 |
42 |
$686.03 |
| 3074F |
|
939 |
930 |
$612.50 |
| 3078F |
|
1,154 |
1,136 |
$582.50 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
135 |
135 |
$573.29 |
| 0064A |
|
13 |
13 |
$404.24 |
| G0008 |
Administration of influenza virus vaccine |
43 |
43 |
$241.39 |
| 90688 |
|
32 |
31 |
$236.87 |
| 3075F |
|
500 |
492 |
$202.50 |
| Q2037 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) |
34 |
34 |
$186.64 |
| 3079F |
|
278 |
273 |
$172.50 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
28 |
28 |
$163.98 |
| 82962 |
|
110 |
107 |
$76.63 |
| 1125F |
|
249 |
248 |
$15.00 |
| 1170F |
|
164 |
163 |
$10.00 |
| 1160F |
|
158 |
157 |
$10.00 |
| 91306 |
|
12 |
12 |
$0.02 |
| 91301 |
|
62 |
62 |
$0.02 |
| 3080F |
|
12 |
12 |
$0.00 |
| 3048F |
|
36 |
36 |
$0.00 |
| 99429 |
|
29 |
27 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
15 |
15 |
$0.00 |
| 3077F |
|
13 |
13 |
$0.00 |